Daniel Wahl

6.3k total citations · 1 hit paper
79 papers, 2.2k citations indexed

About

Daniel Wahl is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Daniel Wahl has authored 79 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 22 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in Daniel Wahl's work include Glioma Diagnosis and Treatment (25 papers), Cancer, Hypoxia, and Metabolism (7 papers) and MRI in cancer diagnosis (6 papers). Daniel Wahl is often cited by papers focused on Glioma Diagnosis and Treatment (25 papers), Cancer, Hypoxia, and Metabolism (7 papers) and MRI in cancer diagnosis (6 papers). Daniel Wahl collaborates with scholars based in United States, Switzerland and Canada. Daniel Wahl's co-authors include Theodore S. Lawrence, Matthew J. Schipper, Weihua Zhou, Erqi L. Pollom, Mary Feng, Matthew H. Stenmark, Gary D. Glick, Elaine M. Caoili, Yebin Tao and Anthony W. Opipari and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Daniel Wahl

72 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma

2015 379 citations Daniel Wahl, Matthew H. Stenmark et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Wahl United States	23	780	503	425	373	353	79	2.2k
Jean–Marie Stassen Belgium	22	802 1.0×	316 0.6×	242 0.6×	436 1.2×	162 0.5×	41	2.4k
Debashis Sarker United Kingdom	25	1.1k 1.4×	1.1k 2.1×	174 0.4×	448 1.2×	184 0.5×	132	2.3k
Ralf A. Hilger Germany	27	1.3k 1.7×	1.2k 2.4×	174 0.4×	374 1.0×	240 0.7×	83	3.2k
David Propper United Kingdom	24	1.1k 1.4×	1.3k 2.7×	662 1.6×	532 1.4×	101 0.3×	78	3.1k
Ala Abudayyeh United States	22	553 0.7×	750 1.5×	229 0.5×	197 0.5×	130 0.4×	80	1.7k
Yohei Masugi Japan	31	857 1.1×	1.1k 2.2×	256 0.6×	617 1.7×	478 1.4×	127	2.9k
Rachel Midgley United Kingdom	26	929 1.2×	1.7k 3.3×	349 0.8×	559 1.5×	168 0.5×	56	2.8k
Catherine Wheeler United States	30	1.1k 1.5×	1.7k 3.4×	217 0.5×	473 1.3×	120 0.3×	73	3.6k
Jinglin Xia China	30	1.2k 1.5×	694 1.4×	325 0.8×	702 1.9×	674 1.9×	107	2.8k
Kyung Hwan Kim South Korea	26	429 0.6×	994 2.0×	509 1.2×	326 0.9×	120 0.3×	95	2.2k

Countries citing papers authored by Daniel Wahl

Since Specialization

Citations

This map shows the geographic impact of Daniel Wahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Wahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Wahl more than expected).

Fields of papers citing papers by Daniel Wahl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Wahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Wahl. The network helps show where Daniel Wahl may publish in the future.

Co-authorship network of co-authors of Daniel Wahl

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Wahl. A scholar is included among the top collaborators of Daniel Wahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Wahl. Daniel Wahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Long, Weiwei Wang, Amanda K. Huber, et al.. (2024). Potentiating the radiation-induced type I interferon anti-tumoral immune response by ATM inhibition in pancreatic cancer. JCI Insight. 9(6). 7 indexed citations

Umemura, Yoshie, Nathan Clarke, Wajd N. Al‐Holou, et al.. (2024). AB036. Targeting glioblastoma de-novo purine metabolism to overcome chemoradiation resistance: an interim result of phase 0/1 clinical trial in newly diagnosed and recurrent glioblastoma. Chinese Clinical Oncology. 13(Suppl 1). AB036–AB036. 1 indexed citations

Kalev, Peter, Nathan Qi, Maureen Kachman, et al.. (2023). Abstract 1095: Exploiting altered methionine metabolism to overcome treatment resistance in glioblastoma. Cancer Research. 83(7_Supplement). 1095–1095. 1 indexed citations

AminiTabrizi, Roya, Hardik Shah, Rosa E. Menjivar, et al.. (2023). Pancreatic tumors exhibit myeloid-driven amino acid stress and upregulate arginine biosynthesis. eLife. 12. 32 indexed citations

Brown, Anna M., Yilun Sun, Michelle M. Kim, et al.. (2022). Efficacy and toxicity with radiation field designs and concurrent temozolomide for CNS lymphoma. Neuro-Oncology Practice. 9(6). 536–544. 1 indexed citations

Halasz, Lia M., Albert Attia, Lisa Bradfield, et al.. (2022). Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline. Practical Radiation Oncology. 12(5). 370–386. 23 indexed citations

Kim, Michelle M., Yilun Sun, Madhava Aryal, et al.. (2021). A Phase 2 Study of Dose-intensified Chemoradiation Using Biologically Based Target Volume Definition in Patients With Newly Diagnosed Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 110(3). 792–803. 25 indexed citations

Lennon, Christopher W., et al.. (2021). Reactive Chlorine Species Reversibly Inhibit DnaB Protein Splicing in Mycobacteria. Microbiology Spectrum. 9(2). e0030121–e0030121. 8 indexed citations

Parsels, Leslie A., Carl G. Engelke, Joshua D. Parsels, et al.. (2020). Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination–Proficient Pancreatic Cancer. Molecular Cancer Therapeutics. 20(2). 263–273. 29 indexed citations

10.

Zhang, Qiang, Michael D. Green, Xueting Lang, et al.. (2019). Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy. Cancer Research. 79(15). 3940–3951. 150 indexed citations

11.

Wahl, Daniel, Michelle M. Kim, Madhava Aryal, et al.. (2018). Combining Perfusion and High B-value Diffusion MRI to Inform Prognosis and Predict Failure Patterns in Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 102(4). 757–764. 18 indexed citations

12.

Parsels, Leslie A., David Karnak, Joshua D. Parsels, et al.. (2017). PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors. Molecular Cancer Research. 16(2). 222–232. 98 indexed citations

13.

Wahl, Daniel, Joseph Dresser, Kari Wilder-Romans, et al.. (2016). Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis. Cancer Research. 77(4). 960–970. 67 indexed citations

14.

Wahl, Daniel, et al.. (2016). Combined Imaging of Elevated CBV and Hypercellularity in Glioblastoma to Inform Management and Intensify Treatment of Resistant Tumor Subvolumes. International Journal of Radiation Oncology*Biology*Physics. 96(2). S182–S183. 3 indexed citations

15.

Wahl, Daniel, Matthew H. Stenmark, Yebin Tao, et al.. (2015). Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma. Journal of Clinical Oncology. 34(5). 452–459. 379 indexed citations breakdown →

16.

Wahl, Daniel & Theodore S. Lawrence. (2015). Integrating chemoradiation and molecularly targeted therapy. Advanced Drug Delivery Reviews. 109. 74–83. 25 indexed citations

17.

Glick, Gary D., Rodrigue Rossignol, Costas A. Lyssiotis, et al.. (2014). Anaplerotic Metabolism of Alloreactive T Cells Provides a Metabolic Approach To Treat Graft-Versus-Host Disease. Journal of Pharmacology and Experimental Therapeutics. 351(2). 298–307. 56 indexed citations

18.

Sundberg, Thomas B., et al.. (2009). Apoptotic Signaling Activated by Modulation of the F0F1-ATPase: Implications for Selective Killing of Autoimmune Lymphocytes. Journal of Pharmacology and Experimental Therapeutics. 331(2). 437–444. 9 indexed citations

19.

Steinberg, Benjamin A., Ariel Roguin, Daniel Wahl, et al.. (2004). 874-2 Reproducibility and interpretation of magneto-cardio-gram maps in detecting ischemia. Journal of the American College of Cardiology. 43(5). A149–A149. 3 indexed citations

20.

Steiner, Sandra, Daniel Wahl, Bonnie L.K. Mangold, et al.. (1996). Induction of the Adipose Differentiation-Related Protein in Liver of Etomoxir-Treated Rats. Biochemical and Biophysical Research Communications. 218(3). 777–782. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact